Why the study?
How does molecular genetic knowledge impact the clinical management of monogenic cardiovascular disorders such as HCM, LQTS, and Marfan syndrome?
How does molecular genetic knowledge impact the clinical management of monogenic cardiovascular disorders such as HCM, LQTS, and Marfan syndrome?
Answers are grounded in this paper and cite their sources.
This review highlights the growing role of molecular genetics in the clinical management of monogenic cardiovascular diseases.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mayosi et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: